Agreement between Orbscan II, VuMAX UBM and Artemis-2 very-high frequency ultrasound scanner for measurement of anterior chamber depth by unknown
Al Farhan BMC Ophthalmology 2014, 14:20
http://www.biomedcentral.com/1471-2415/14/20RESEARCH ARTICLE Open AccessAgreement between Orbscan II, VuMAX UBM and
Artemis-2 very-high frequency ultrasound scanner
for measurement of anterior chamber depth
Haya Matuoq Al FarhanAbstract
Background: The aim was to compare the anterior chamber depth (ACD) measurements taken with Orbscan II,
ultrasound biomicroscopy (UBM) and the Artemis-2 VHF (very-high-frequency) ultrasound scanner in normal
subjects.
Methods: In this prospective study, one eye from each of 60 normal subjects was randomly selected. Three
subjects dropped out of the study because they were apprehensive about the UBM examination; their data were
excluded entirely. Measurements of ACD were taken with the Orbscan II, UBM and Artemis-2 VHFUS. Results were
obtained for coefficient of variance (CV) and intra-class correlation coefficient (ICC), and statistical analysis was by
repeated-measures analysis of variance (ANOVA) for intra-observer repeatability. ANOVA and Bland–Altman analyses
were used to determine limits of agreement (LOA) between the three instruments.
Results: The average ACD (± standard deviation) was 3.13 ± 0.34 mm, 2.96 ± 0.27 mm and 2.87 ± 0.31 mm for the
Orbscan II, UBM and Artemis-2 VHFUS, respectively. The repeatability scores were 0.015 ± 0.014%, 0.08 ± 0.09% and
0.07 ± 0.06% for the Orbscan II, UBM and Artemis-2 VHFUS, respectively. The ICC for repeatability of Orbscan II, UBM
and Artemis-2 VHFUS measurements was high and equal to 0.99%. The intra-observer repeatability scores of the
ACD measurement p-values using Orbscan II, UBM and Artemis-2 VHFUS were 0.12, 0.70 and 0.10, respectively. The
mean difference and standard deviations for ACD measurements using Orbscan II vs UBM, Orbscan II vs Artemis-2
VHFUS and UBM vs Artemis-2 VHFUS were 0.17 ± 0.31 mm, 0.27 ± 0.34 mm and 0.10 ± 0.18 mm, respectively. LOAs
were 0.78 to −0.44 mm, 0.93 to −0.39 mm and 0.45 to −0.26 mm. ANOVA revealed a statistically significant
difference between the Orbscan II, UBM and Artemis-2 VHFUS (p < 0.0001).
Conclusions: Measurements by the three instruments show high repeatability. UBM and the Artemis-2 VHFUS can
be used interchangeably, but the Orbscan II cannot be used interchangeably with UBM or the Artemis-2 VHFUS.
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Ultrasound scannerBackground
It is well-documented that anterior chamber depth
(ACD) measurement is essential as a screening method
for primary angle-closure glaucoma [1,2]; it is also used
in biometry to calculate the power of intraocular lenses
(IOLs) [3], for determining the precise optic zoneCorrespondence: halfarhan@ksu.edu.sa
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reproduction in any medium, provided the orablation diameter in keratorefractive surgery [4], and in
postoperative assessments [5].
Recently, new techniques have been introduced to as-
sess ACD using either ultrasonic or optical technologies
[6]. Ultrasonic immersion instruments include the ultra-
sound biomicroscope (UBM; Sonomed Inc., New York,
USA) [7-9] and the Artemis-2 VHFUS scanner (Scott
Philips Engineering, Victoria, BC, Canada) [10]. Optical
methods that have been studied include anterior seg-
ment optical coherence tomography (OCT) [11] and
Scheimpflug imaging [12].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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measurements of ACD. Optical methods are objective,
however it is difficult to accurately measure ACD in the
presence of edema, opacities, scarring or deposits in
the optical media [12]. In contrast, ultrasound-based
methods do not require clear optical media to obtain
precise measurements of ACD. There are disadvantages
of UBM: for example, the examiner must manually ad-
just the transducer head to maximize centrality and
perpendicularity of the image, which takes time, and
analog-based UBM does not image the interface consist-
ently because analog processing does not produce a high
enough signal-to-noise ratio between the interface echo
complex and the surrounding tissue [13].
Previous studies have investigated the agreement be-
tween ACD measurements obtained with these different
instruments [7-13] but, to the best of our knowledge,
this is the first study to compare measurements obtained
with these devices in normal eyes. The aim of this study
was to assess the repeatability and agreement of ACD
measurements obtained using the Orbscan II topography
system, UBM and the Artemis-2 VHFUS.
Methods
The study enrolled 60 consecutive, healthy, oculovisually
normal subjects (33 right eyes and 27 left eyes) aged
19–30 years (22 ± 2 years). Comprehensive anterior seg-
ment examinations of all eyes were performed using a
slit lamp. The exclusion criteria were: history of any
intraocular or corneal surgery; contact lens wear; sys-
temic diseases such diabetes mellitus; intraocular pres-
sure (IOP) of 20 mmHg or more; corneal anomalies;
spherical refraction of 4.00 diopters (D) or more; or cy-
lindrical refraction of 2.00 D or more [10]. Spherical
and cylindrical refractions and IOPs were determined
by autorefractometry (Auto Kerato-Refracto-Tonometer
TRK-1P-Topcon, Inc., Tokyo, Japan).
One eye was randomly selected in each subject using a
table generated on Microsoft < tm > Excel. All measure-
ments were obtained in the afternoon and between
12:00 PM and 3:00 PM [14] by a single investigator, in
the same clinic at one location, under mesopic condi-
tions [13]. ACD was defined as the measured distance
from the corneal endothelium to the anterior lens
surface.
Measurements were first taken using the non-invasive
Orbscan II technique, and followed by the Artemis-2
VHFUS. This sequence was intended to control for any
variations in central corneal thickness caused by changes
in the resistance of the cornea from indentation [15].
Eyes were then rested for 1 hour, after which UBM was
used; this rest period was avoided any inadvertent cor-
neal indentation errors during UBM [16]. Three re-
peated measurements were obtained consecutively byeach method, for each eye. These measurements were
then compared to obtain repeatability scores for each in-
strument and agreement between the instruments. Three
subjects dropped out of the study when they became ap-
prehensive about the UBM examination. All of their as-
sociated data were excluded from the analysis.
The purpose of the study was explained to all subjects
and informed consent was obtained from each before
the examination began. The study conformed with the
ethical considerations laid out in the 2008 Declaration of
Helsinki and the study protocol was approved by the re-
search ethics review board of the College of Applied
Medicine Science at King Saud University.Orbscan II method
The Orbscan II (Bausch & Lomb, Rochester, NY, USA)
is a non-contact optical computerized slit-scanning top-
ography system. It quantifies elevation differences be-
tween the anterior and posterior corneal surfaces, the
anterior surfaces of the iris and the lens, and automatic-
ally compensates for differences in refraction from the
corneal endothelial surface using a ray-trace algorithm,
to provide accurate and reproducible measurements of
ACD from both surfaces of the cornea to the anterior
surface of the crystalline lens along the optical axis. Each
subject was seated in a typical normal position using the
chin-rest; the instrument was aligned and scans were
made of the cornea. The system software then automat-
ically detected the corneal endothelial surface and anter-
ior surface of the crystalline lens on the acquired
images, compensating for differences in refraction from
the corneal anterior surface using a ray-trace algorithm,
and calculating ACD [17].Artemis-2 VHFUS method
The Artemis-2 VHFUS (Scott Philips Engineering, Victoria,
BC, Canada) has an advantage over other instruments in
that during scanning, the probe is moved in an arc-
shaped trajectory which is matched approximately to
the corneal curvature, enabling near-normal incidence
at all positions. The device incorporates a fixation light
and optical camera for visualization of the eye to assure
centration [18]. With the subject in the seated position,
and his or her face on a three-point forehead and chin-
rest, the eye is placed into a soft-rimmed eye-cup simi-
lar to that in swimming goggles. The compartment in
front of the eye was filled with a sterile coupling fluid
filled and scanning was performed via an ultrasonically
transparent (sterile) membrane, without the need for
a speculum. Thus, there was no contact between the
scanner probe and the eye. The 3-D scan took 2–3
minutes for each eye.
Table 1 The intra-observer coefficient of variance (CV) (%) in anterior chamber depth (ACD) measurements and
intra-session repeatability for Orbscan II, Artemis-2 and UBM evaluated by intra-class correlation coefficient (ICC)
Orbscan II Artemis 2 UBM
CV mean ± SD (%) 0.015 ± 0.014 0.08 ± 0.09 0.07 ± 0.06
Significance of differences between CVs (p value) 0.12 0.10 0.70
ICC (95% CI) 0.990 (0.984–0.994) 0.990 (0.984–0.994) 0.990 (0.984–0.994)
CI, confidence interval; SD, standard deviation; UBM, ultrasound biomicroscopy.
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The UBM is an immersion technique that uses a high-
frequency (50 MHz) ultrasound beam to measure vari-
ous ocular parameters. The examiner manually adjusts
the transducer head to maximize the centrality and per-
pendicularity of the images, which can be a time-
consuming process. The VuMAX™ UBM (Sonomed Inc.,
NY, USA) was used. First, one drop of topical anesthesia
(0.4% benoxinate hydrochloride) was instilled in the sub-
ject’s eye. The eye-cup was disinfected with an alcohol
swab and filled with a 1% methylcellulose solution. The
transducer head was immersed in this solution and the
eye cup was placed on the sclera of the eye. The subject
was then asked to look at a fixation target on the ceiling
in order to maintain steady accommodation and fixation
while the image was obtained.
Statistical methods
The data for all subjects were analyzed using Microsoft
Excel 2007 < tm>. For data analysis, Medcalc software
(version 11.4.4.0) was used. Coefficient of variance (CV)
was used to show the extent of variability in relation to
mean of the population. The intra-class correlation coef-
ficient (ICC) was used to assess inter-rater reliability.
Repeated-measures analysis of variance (ANOVA) was
used to test the statistical significance of the repeatability
of three intra-observer readings, and of the mean of
the three readings from the three instruments. Bland–
Altman analyses were applied to determine limits of
agreement (LOA) between the instruments. All tests
were two-tailed. The level of statistical significance for
this study was set at 0.05.
Results
The study included 60 normal eyes. The mean spherical
equivalent refractive error ± standard deviation (SD) wasTable 2 The mean differences ± standard deviation (SD), limit
anterior chamber depth (ACD) measurements using the three
Mean difference ± SD
Orbscan II vs UBM 0.17 ± 0.31 mm
Orbscan II vs Artemis-2 VHFUS 0.27 ± 0.34 mm
UBM vs Artemis-2 VHFUS 0.10 ± 0.18 mm
UBM, ultrasound biomicroscopy; VHFUS, very high-frequency ultrasound scanner. *P−0.50 ± 1.00 D. The mean IOP (± SD) was 14.00 ± 2 mmHg.
The mean ACD (± SD) measurements using Orbscan II,
UBM and Artemis-2 VHFUS were 3.13 ± 0.34 mm, 2.96 ±
0.27 mm and 2.87 ± 0.31 mm, respectively.
Intra-observer repeatability of ACD measurements
The intra-observer repeatability of ACD measurements
with Orbscan II, UBM and Artemis-2 VHFUS are sum-
marized in Table 1. The intra-session reproducibility of
ACD measurements was excellent for all three instru-
ments as shown by the high ICCs, which are shown in
Table 1.
Agreement between the three instruments
The mean differences, SDs, LOA and pairwise compari-
sons (using p-values) for ACD measurements using the
Orbscan II, UBM and Artemis-2 VHFUS are summa-
rized in Table 2. There was a statistically significant dif-
ference between mean ACD measured with the Orbscan
II, UBM and Artemis-2 VHFUS, as determined by
ANOVA (p = 0.0001). Pairwise comparisons of the
Orbscan II vs UBM and Orbscan II vs Artemis-2 VHFUS
showed a statistically significant difference (p <0.01 and
p < 0.001, respectively), but there was no statistically sig-
nificant difference found for UBM vs Artemis-2 VHFUS
(p > 0.05; Table 2). The mean difference percentage of
ACD measurements for UBM and Artemis-2 VHFUS
was 3.1%. Bland–Altman plots of the mean differences
and LOA of ACD measurements using the three instru-
ments are shown in Figures 1, 2 and 3, respectively).
Discussion
An accurate ACD measurement is required to prevent
endothelial damage during cataract surgery [19] and in
cases of IOL complications that require removal or ex-
change, such as unexpected or unintended refractives of agreement and pair-wise comparisons of p-values for
instruments
Limits of agreement p-values*
0.80 to − 0.43 mm < 0.01
0.94 to − 0.39 mm < 0.001
0.45 to − 0.26 mm > 0.05
airwise comparison.
Figure 1 Bland–Altman plot of agreement showing the mean differences and limits of agreement of anterior chamber depth (ACD)
measurements between UBM and Orbscan II.
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of ACD is also a common technique in pseudophakic
eyes, for evaluating the possibility of IOL movement
during accommodation [21]. Additionally, several studies
report that ACD can be used to predict glaucoma,
whereby a shallow ACD increases the risk of developing
acute and chronic angle-closure glaucoma [1,2].
In the present study, the intra-observer repeatability
of ACD measurements using the Orbscan II, UBM
and Artemis-2 VHFUS was not significantly different
(p ≤ 0.05). The CVs and ICCs demonstrated high levels
of consistency and repeatability for the three instru-
ments. The Bland–Altman analysis of the ACD mea-
surements showed poor LOA between the Orbscan II vsFigure 2 Bland–Altman plot of agreement showing the mean differen
measurements between UBM and Artemis-2 VHFUS.UBM and the Artemis-2 VHFUS, respectively. However,
there was a high level of agreement between the UBM
and the Artemis-2 VHFUS. The mean difference was
0.09 mm, which is insufficient to affect decisions related
to refractive surgery in clinical practice. The ANOVA
indicated a statistically significant difference between
Orbscan II, UBM and Artemis-2 VHFUS for ACD mea-
surements (p = 0.0001), although the p-values of the
pairwise comparisons of mean ACD measurements by
Orbscan II vs UBM, Orbscan II vs Artemis-2 VHFUS, and
UBM vs Artemis-2 VHFUS were 0.01, 0.001 and 0.05, re-
spectively. The mean ACD measured with Orbscan II vs
UBM and Artemis-2 VHFUS was significantly different;
this demonstrates that these instruments cannot be usedces and limits of agreement of anterior chamber depth (ACD)
Figure 3 Bland–Altman plot of agreement showing the mean differences and limits of agreement of anterior chamber depth (ACD)
measurements between Orbscan II and Artemis-2 VHFUS.
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using UBM and Artemis-2 VHFUS were not significantly
different and, therefore, these instruments can be used
interchangeably. Moreover, the mean difference percent-
age for ACD measurements was 3.1%, which further indi-
cates that ACD measurements using UBM and Artemis-2
VHFUS are equally valid.
A number of studies have reported high intra-observer re-
peatability of ACD measurements obtained using Orbscan II,
UBM and Artemis-2 VHFUS in normal eyes [8,9,11,22].
Our results show high intra-observer consistency and
repeatability of ACD measurements obtained with all
three instruments.
Previous studies comparing ACD measurements ob-
tained by optical and contact ultrasonic instruments
reported small differences between different optical
techniques (< 5%), yet larger differences (10–15%) have
been reported with different contact ultrasonic tech-
niques [23,24]. Furthermore, ACD measurements made
by contact ultrasonic techniques are consistently about
0.40 mm smaller than those measured using optical tech-
niques, such as Orbscan and anterior-segment OCTTable 3 Overview of recent studies comparing the repeatabil
chamber depth (ACD)
Author (year) Instruments Parameter Mean a
Lee et al. (2007) [7] Orbscan II* vs UBM** ACD 44.25
Hashemi et al. (2005) [30] Orbscan I* vs USP† ACD 30.2 ± 8
Chaidaroon and Jengialern
(2005) [31]
Orbscan I* vs IOL Master* ACD 27.90 ±




‡In all studies the difference between instruments was statistically significant.[9,23], and about 0.30 mm less than those obtained with
immersion ultrasound [24]; this might be due to the
mechanical applanation effect that occurs when the ultra-
sound probe touches the cornea. Our results show that
the difference (expressed as a percentage) for UBM vs
Artemis-2 VHFUS was 3.1%, which is comparable to that
previously reported for optical techniques. The mean dif-
ferences of the ACD measurements using UBM and the
Artemis-2 VHFUS were less than those for the Orbscan II
– by 0.18 mm and 0.27 mm, respectively. This is probably
because the ultrasonic instruments used in this study em-
ploy immersion techniques that reduce any mechanical
applanation effect.
Some studies have reported that ACD measurements
change according to the accommodative status of the
eye [25,26]. For instance, in a comparison of Orbscan II
vs anterior segment OCT or Scheimpflug camera in nor-
mal healthy subjects (mean age 23.3–25 years), mean
ACD measurements ranged from 0.10–0.15 mm and
0.08–0.23 mm, respectively [11,15,27]. This might be be-
cause Orbscan II and Scheimpflug cameras do not have
fixation systems to block accommodation of the eye,ity of different instruments for measuring anterior
ge ± SD Spherical equivalent range Agreement between results?‡
−5.50 to + 3.00 D No
.5 −15.00 to − 1.00 D No
8.80 −8.49 ± 4.00 D No
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ation light and optical camera for visualization of
the eye to assure centration [4,10,15]. The Artemis-2
VHFUS used in this study incorporates both fixation
light and optical camera for visualizing the eye and
ensuring centration. During the UBM examination, sub-
jects were instructed to fixate on a ceiling target to
maintain accommodation. During the scanning session,
the examiner looked for any decentration or loss of fix-
ation [28]. Our results show there were no statistically
significant differences between UBM and Artemis-2
VHFUS, most likely due to similarity between the tech-
niques and constant fixation.
Previous studies have shown variations in the mean
ACD value obtained by different instruments, which
may be due to differences in sample size, study popula-
tion [7,23,29,30] and refractive error [7,23,29,31]. Table 3
summarizes the results from three recent studies looking
at the repeatability of different instruments for measur-
ing ACD. Lee et al. [7] reported that ACD measure-
ments (mean ± SD) from Orbscan II and UBM were
2.82 ± 0.46 mm and 2.91 ± 0.43 mm, respectively. The
mean difference was 0.09 ± 0.09 mm and the p-value
was 0.001, indicating that instruments cannot be used
interchangeably [7]. Our results also show that the
Orbscan II, UBM and Artemis-2 VHFUS cannot be used
interchangeably. However, the mean differences of the
ACD measurements of Orbscan II vs UBM and Orbscan
II vs Artemis-2 VHFUS in our study were slightly higher
than their results, possibly because of differences in the
subjects; their study was on older subjects (mean age
44.25 years) and some had cataracts [29]. Although there
was just one observer in this study, which may be con-
sidered as a potential limitation, there was a high degree
of intra-observer agreement.
Conclusions
All three instruments in this study demonstrated high
repeatability. In terms of obtaining measurements of
ACD, the Orbscan II cannot be used interchangeably
with UBM or Artemis-2 VHFUS, but the UBM and
Artemis-2 VHFUS can be used interchangeably for the
measurement of ACD.
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